These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 32698190)
1. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Hoffmann M; Mösbauer K; Hofmann-Winkler H; Kaul A; Kleine-Weber H; Krüger N; Gassen NC; Müller MA; Drosten C; Pöhlmann S Nature; 2020 Sep; 585(7826):588-590. PubMed ID: 32698190 [TBL] [Abstract][Full Text] [Related]
2. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. Yamamoto M; Kiso M; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Imai M; Takeda M; Kinoshita N; Ohmagari N; Gohda J; Semba K; Matsuda Z; Kawaguchi Y; Kawaoka Y; Inoue JI Viruses; 2020 Jun; 12(6):. PubMed ID: 32532094 [TBL] [Abstract][Full Text] [Related]
3. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Yao X; Ye F; Zhang M; Cui C; Huang B; Niu P; Liu X; Zhao L; Dong E; Song C; Zhan S; Lu R; Li H; Tan W; Liu D Clin Infect Dis; 2020 Jul; 71(15):732-739. PubMed ID: 32150618 [TBL] [Abstract][Full Text] [Related]
4. H Yang G Am J Physiol Cell Physiol; 2020 Aug; 319(2):C244-C249. PubMed ID: 32515982 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. Wang S; Li W; Hui H; Tiwari SK; Zhang Q; Croker BA; Rawlings S; Smith D; Carlin AF; Rana TM EMBO J; 2020 Nov; 39(21):e106057. PubMed ID: 32944968 [TBL] [Abstract][Full Text] [Related]
11. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029 [No Abstract] [Full Text] [Related]
12. In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Pizzorno A; Padey B; Dubois J; Julien T; Traversier A; Dulière V; Brun P; Lina B; Rosa-Calatrava M; Terrier O Antiviral Res; 2020 Sep; 181():104878. PubMed ID: 32679055 [TBL] [Abstract][Full Text] [Related]
13. Chloroquine as a prophylactic agent against COVID-19? Gendrot M; Javelle E; Clerc A; Savini H; Pradines B Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495 [TBL] [Abstract][Full Text] [Related]
14. Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing. Zecha J; Lee CY; Bayer FP; Meng C; Grass V; Zerweck J; Schnatbaum K; Michler T; Pichlmair A; Ludwig C; Kuster B Mol Cell Proteomics; 2020 Sep; 19(9):1503-1522. PubMed ID: 32591346 [TBL] [Abstract][Full Text] [Related]
15. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle. Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797 [TBL] [Abstract][Full Text] [Related]
16. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Devaux CA; Rolain JM; Colson P; Raoult D Int J Antimicrob Agents; 2020 May; 55(5):105938. PubMed ID: 32171740 [TBL] [Abstract][Full Text] [Related]
17. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
18. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Yuan S; Chan JFW; Chik KKH; Chan CCY; Tsang JOL; Liang R; Cao J; Tang K; Chen LL; Wen K; Cai JP; Ye ZW; Lu G; Chu H; Jin DY; Yuen KY Pharmacol Res; 2020 Sep; 159():104960. PubMed ID: 32473310 [TBL] [Abstract][Full Text] [Related]
19. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Hoffmann M; Kleine-Weber H; Pöhlmann S Mol Cell; 2020 May; 78(4):779-784.e5. PubMed ID: 32362314 [TBL] [Abstract][Full Text] [Related]
20. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19). Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]